CordenPharma Colorado

Global CDMO operating the world's largest Solid-Phase Peptide Synthesis (SPPS) plant in Boulder, CO. cGMP-certified, FDA-inspected facility. 10,000L SPPS reactors with >2 metric tons annual capacity. Full lifecycle peptide API services from process development through commercial ton-scale production. €900M expansion underway (2024-2028) to more than double capacity. Also operates a second Boulder site for HPAPIs acquired from Pfizer/Hospira. Part of CordenPharma Group (Astorg portfolio).

Directory assessment: CordenPharma Colorado is listed as a CDMO in the peptide supply chain, serving North America markets from USA (Boulder, CO). As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. This profile lists 3 sources for reference. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.